• No results found

Adoptive transfer of tumor- and minor antigen-specific T cell reactivity in mouse models

N/A
N/A
Protected

Academic year: 2021

Share "Adoptive transfer of tumor- and minor antigen-specific T cell reactivity in mouse models"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Adoptive transfer of tumor- and minor antigen-specific T cell reactivity in mouse models

Witte, M.A. de

Citation

Witte, M. A. de. (2008, May 29). Adoptive transfer of tumor- and minor antigen-specific T cell reactivity in mouse models. Retrieved from https://hdl.handle.net/1887/12870

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12870

Note: To cite this publication please use the final published version (if applicable).

(2)

Adoptive transfer of

tumor- and minor antigen-specific

T cell reactivity in mouse models

(3)
(4)

Adoptive transfer of

tumor- and minor antigen-specific T cell reactivity in mouse models

Proefschrift ter verkrijging van

de graad van Doctor aan de Universiteit van Leiden, op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden,

volgens het besluit van het College voor Promoties te verdedigen op donderdag 29 mei 2008

klokke 13.45 door

Moniek Angenies de Witte geboren te Nijmegen

in 1976

(5)

Promotiecommissie:

Promotor: Prof. Dr. T.N.M. Schumacher Referent: Prof. Dr. J.H.F. Falkenburg

Overige leden: Prof. Dr. J. Borst (Universiteit van Amsterdam) Prof. Dr. M.H. van Oers (Universiteit van Amsterdam)

Prof. Dr. H.J. Stauss (University College London, United Kingdom) Prof. Dr. J.J. Neefjes

(6)

Het geluk zit in een klein boekje…

Aan mijn familie

(7)

The studies described in this thesis were performed at the Department of Immunology at the Netherlands Cancer Institute (NKI), Amsterdam.

This study was financially supported by grants from the Netherlands Organization for Scientific Research (NWO Pioneer grant 00-03) and the EU 6th Framework program (ATTACK).

The printing of this thesis was financially supported by:

- Stichting AMSTOL - BD Biosciences - Corning BV

(8)

Contents

Chapter 1: General introduction 9

Chapter 2: Feasibility of removal of MiHAg-specific T cell responses and consequences for Graft versus Host Disease.

Blood 109: 3830-8 (2007)

17

Chapter 3: Prospects and limitations of T cell receptor gene therapy.

Curr Gene Ther. 5: 583-93 (2005)

29

Chapter 4: Targeting self antigens through allogeneic TCR gene transfer.

Blood 108: 870-7 (2006)

43

Chapter 5: Assessing TCR gene therapy and vaccination in spontaneous prostate carcinoma in mice.

Journal of Immunology, accepted for publication

59

Chapter 6: Requirements for effective anti-tumor responses of TCR transduced T cells.

Submitted for publication

77

Chapter 7: An inducible caspase 9 safety switch can halt cell therapy- induced autoimmune disease.

Journal of Immunology, in press

97

Chapter 8: General discussion 115

Summary 133

Nederlandse samenvatting 135

Curriculum Vitae 139

List of publications 141

(9)

Referenties

GERELATEERDE DOCUMENTEN

Importantly, in mice treated by vaccination only, the incidence of carcinomas in prostate glands (100% of mice) and coagulation glands (55% of mice), and the incidence of adenomas

Importantly, the reduced numbers of TCR modified T cells obtained in vivo upon infusion of grafts with a high number of passenger cells was associated with a substantially

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect

Men zou zich kunnen voorstellen dat wanneer T cellen worden ‘heropgevoed’ om ‘eigen eiwitten’ op kankercellen te gaan herkennen, er wellicht ook een risico bestaat dat

Adoptive transfer of tumor- and minor antigen-specific T cell reactivity in mouse models..

The work described in this thesis was performed at the Department of Tu- mor Biology of the Netherlands Cancer Institute, Amsterdam, The Netherlands. This work was supported by

The work described in this thesis was performed at the Division of Tumor Biology of the Netherlands Cancer Institute, Amsterdam, The Netherlands, and supported by grants from the

The research described in this thesis was performed at the Division of Tumor Biology of the Netherlands Cancer Institute (NKI/AvL) and supported by The Netherlands Organization